Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ABCB10 EST20237, M-ABC2, MTABC2 ENSG00000135776 ATP-binding cassette, sub-family B (MDR/TAP), member 10 1 229516582-229558695 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB044063, CAB044065, HPA055175 Uncertain Expressed in all bone marrow: 36.6 ABCC4 EST170205, MOAT-B, MOATB, MRP4 ENSG00000125257 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 13 95019829-95301446 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002476 Supported Approved Nucleoli
Plasma membrane
Cytosol Tissue enhanced 0 prostate: 68.5 epididymis: 23.3 ABCG2 ABCP, BCRP, CD338, EST157481, MXR ENSG00000118777 ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) 4 88090264-88231322 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037299, HPA054719 Supported Validated Nucleus
Plasma membrane Tissue enhanced 0 small intestine: 116.1 seminal vesicle: 55.4 ABCG5 STSL ENSG00000138075 ATP-binding cassette, sub-family G (WHITE), member 5 2 43812472-43838865 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA016514 Approved Approved Nucleus Group enriched 32 duodenum: 58.0;liver: 28.3;small intestine: 57.4 gallbladder: 1.4 ADRA1A ADRA1C, ADRA1L1 ENSG00000120907 Adrenoceptor alpha 1A 8 26748150-26867273 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029678, HPA029679 Approved Tissue enhanced 0 adipose tissue: 22.6;liver: 32.0 seminal vesicle: 19.5 ADTRP AIG1L, C6orf105, dJ413H6.1 ENSG00000111863 Androgen-dependent TFPI-regulating protein 6 11712054-11807046 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA048113 Uncertain Uncertain Nucleoli Tissue enhanced 0 small intestine: 81.0 duodenum: 62.8 ALG9 DIBD1 ENSG00000086848 ALG9, alpha-1,2-mannosyltransferase 11 111782195-111871581 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038575 Approved Approved Endoplasmic reticulum Expressed in all testis: 25.3 AMFR gp78, RNF45 ENSG00000159461 Autocrine motility factor receptor, E3 ubiquitin protein ligase 16 56361452-56425538 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026381, HPA029018, HPA077835 Approved Supported Endoplasmic reticulum
Golgi apparatus Expressed in all testis: 154.3 AQP1 CHIP28, CO ENSG00000240583 Aquaporin 1 (Colton blood group) 7 30911855-30925516 Blood group antigen proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001707, HPA019206 Supported Supported Plasma membrane Expressed in all kidney: 801.2 AQP10 ENSG00000143595 Aquaporin 10 1 154321090-154325325 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA065947 Supported Group enriched 8 duodenum: 70.3;small intestine: 50.1 fallopian tube: 7.1 AQP2 ENSG00000167580 Aquaporin 2 (collecting duct) 12 49950741-49958881 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046834 Supported Group enriched 93 kidney: 432.9;seminal vesicle: 299.3 prostate: 3.9 AQP3 GIL ENSG00000165272 Aquaporin 3 (Gill blood group) 9 33441154-33447611 Blood group antigen proteins, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014924 Supported Supported Nucleus
Plasma membrane Expressed in all esophagus: 975.2 AQP4 MIWC ENSG00000171885 Aquaporin 4 18 26852038-26865818 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005079, HPA014784, CAB058689 Supported Supported Supported Plasma membrane
Cell Junctions Group enriched 17 cerebral cortex: 631.8;lung: 172.2 thyroid gland: 24.3 AQP5 ENSG00000161798 Aquaporin 5 12 49961870-49965681 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065008 Supported Approved Plasma membrane Group enriched 8 salivary gland: 257.1;stomach: 54.0;testis: 176.5 breast: 21.0 AQP6 AQP2L ENSG00000086159 Aquaporin 6, kidney specific 12 49967194-49977139 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA015278 Supported Tissue enriched 9 kidney: 20.8 cerebral cortex: 2.3 ARL6IP1 AIP1, ARL6IP, ARMER, KIAA0069, SPG61 ENSG00000170540 ADP-ribosylation factor-like 6 interacting protein 1 16 18791667-18801678 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045307 Uncertain Approved Endoplasmic reticulum Expressed in all cerebral cortex: 388.0 ATG9A APG9L1, FLJ22169 ENSG00000198925 Autophagy related 9A 2 219209772-219229717 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059551 Uncertain Supported Vesicles Expressed in all testis: 112.6 ATP11A ATPIH, ATPIS, KIAA1021 ENSG00000068650 ATPase, class VI, type 11A 13 112690329-112887168 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035583, HPA035584 Approved Validated Vesicles Expressed in all lung: 59.2 ATP7A MNK ENSG00000165240 ATPase, Cu++ transporting, alpha polypeptide X 77910656-78050395 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012887, HPA048107 Approved Supported Golgi apparatus
Vesicles Mixed parathyroid gland: 15.0 AVPR2 DIR, DIR3, V2R ENSG00000126895 Arginine vasopressin receptor 2 X 153902531-153907166 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA046678 Approved Tissue enhanced 0 adipose tissue: 5.8 heart muscle: 2.8 BDKRB1 B1BKR, BKR1, bradyb1 ENSG00000100739 Bradykinin receptor B1 14 96255824-96268967 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA002935 Approved Tissue enhanced 0 gallbladder: 18.3;urinary bladder: 10.3 appendix: 7.0 CACNA1A APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6 ENSG00000141837 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19 13206442-13623990 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064258 Supported Approved Nucleoplasm
Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 18.1 stomach: 6.4 CACNA1E BII, CACH6, CACNL1A6, Cav2.3 ENSG00000198216 Calcium channel, voltage-dependent, R type, alpha 1E subunit 1 181413102-181808084 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042515 Approved Plasma membrane
Actin filaments
Cytosol Tissue enriched 7 cerebral cortex: 10.3 adrenal gland: 1.3 CACNA1H Cav3.2 ENSG00000196557 Calcium channel, voltage-dependent, T type, alpha 1H subunit 16 1153241-1221771 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA039125 Approved Approved Nucleoplasm
Vesicles Tissue enhanced 0 ovary: 50.6 seminal vesicle: 46.9 CATSPER4 ENSG00000188782 Cation channel, sperm associated 4 1 26190561-26202968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA045257 Supported Tissue enriched 63 testis: 9.7 skin: 0.1 CCR2 CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R ENSG00000121807 Chemokine (C-C motif) receptor 2 3 46353734-46360928 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB003793 Approved Tissue enhanced 0 appendix: 53.0 spleen: 20.8 CD47 IAP, MER6, OA3 ENSG00000196776 CD47 molecule 3 108043298-108091025 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016055, HPA044659 Approved Supported Golgi apparatus
Vesicles
Plasma membrane Expressed in all lung: 204.9 CECR6 ENSG00000183307 Cat eye syndrome chromosome region, candidate 6 22 17116299-17121367 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA068790 Approved Nucleoplasm
Vesicles
Plasma membrane Group enriched 7 cerebral cortex: 15.0;prostate: 10.9 testis: 1.9 CERS1 LAG1, LASS1, UOG1 ENSG00000223802 Ceramide synthase 1 19 18868545-18896727 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045724 Approved Approved Endoplasmic reticulum Group enriched 13 cerebral cortex: 136.6;testis: 28.0 skeletal muscle: 6.5 CERS2 FLJ10243, LASS2, SP260 ENSG00000143418 Ceramide synthase 2 1 150960583-150975004 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027262 Approved Supported Nuclear membrane
Endoplasmic reticulum Expressed in all liver: 408.6 CERS4 FLJ12089, LASS4, Trh1 ENSG00000090661 Ceramide synthase 4 19 8206736-8262421 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB033734, HPA054729 Uncertain Approved Nucleus
Vesicles Mixed thyroid gland: 80.7 CLCN3 ClC-3, CLC3 ENSG00000109572 Chloride channel, voltage-sensitive 3 4 169612633-169723673 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044723 Approved Approved Cytosol Expressed in all cerebral cortex: 104.4 CLN3 BTS, JNCL ENSG00000188603 Ceroid-lipofuscinosis, neuronal 3 16 28477279-28495575 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA063280 Uncertain Expressed in all placenta: 54.9 CLPTM1 ENSG00000104853 Cleft lip and palate associated transmembrane protein 1 19 44954585-44993341 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA068702 Approved Nuclear membrane
Microtubule organizing center Expressed in all parathyroid gland: 127.5 CLPTM1L CRR9, FLJ14400 ENSG00000049656 CLPTM1-like 5 1317744-1345099 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014791 Approved Approved Endoplasmic reticulum Expressed in all testis: 54.1 CTNS CTNS-LSB, PQLC4 ENSG00000040531 Cystinosin, lysosomal cystine transporter 17 3636468-3661542 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046947 Supported Vesicles
Intermediate filaments Expressed in all testis: 43.3 CYB561 CYB561A1, FRRS2 ENSG00000008283 Cytochrome b561 17 63432304-63446378 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014753 Approved Expressed in all adrenal gland: 164.3 CYB561A3 CYBASC3 ENSG00000162144 Cytochrome b561 family, member A3 11 61348745-61362299 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052548 Uncertain Expressed in all adrenal gland: 188.0 CYB561D1 FLJ39035, FLJ44753 ENSG00000174151 Cytochrome b561 family, member D1 1 109494052-109502932 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA027028 Uncertain Mixed skin: 21.4 CYB561D2 101F6, TSP10 ENSG00000114395 Cytochrome b561 family, member D2 3 50350695-50358460 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042817 Uncertain Expressed in all epididymis: 28.3 CYBRD1 CYB561A2, DCYTB, FLJ23462, FRRS3 ENSG00000071967 Cytochrome b reductase 1 2 171522247-171558133 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014757, HPA056736 Approved Approved Golgi apparatus
Cytosol Expressed in all thyroid gland: 379.4 DAGLA C11orf11, DAGLALPHA, KIAA0659, NSDDR ENSG00000134780 Diacylglycerol lipase, alpha 11 61680433-61747001 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062497 Approved Tissue enriched 6 cerebral cortex: 18.6 colon: 3.1 DCST1 FLJ32785 ENSG00000163357 DC-STAMP domain containing 1 1 155033824-155050930 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA060314 Uncertain Group enriched 5 skin: 3.7;testis: 6.2 small intestine: 0.9 DERL2 CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa ENSG00000072849 Derlin 2 17 5471251-5486811 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037287, HPA048957, HPA056551 Supported Supported Endoplasmic reticulum Expressed in all thyroid gland: 41.3 DNAJC22 FLJ13236, wus ENSG00000178401 DnaJ (Hsp40) homolog, subfamily C, member 22 12 49346917-49357546 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA039953 Approved Vesicles Mixed thyroid gland: 17.9 DPY19L4 ENSG00000156162 Dpy-19-like 4 (C. elegans) 8 94719703-94793836 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024780 Approved Approved Vesicles Expressed in all parathyroid gland: 36.2 DRAM2 MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154 ENSG00000156171 DNA-damage regulated autophagy modulator 2 1 111117333-111140216 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018036, HPA061701 Supported Validated Golgi apparatus
Vesicles Mixed spleen: 19.8 EI24 EPG4, PIG8, TP53I8 ENSG00000149547 Etoposide induced 2.4 11 125569216-125584687 Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047165, HPA051029 Uncertain Supported Endoplasmic reticulum
Golgi apparatus
Cytosol Tissue enriched 9 parathyroid gland: 1098.6 liver: 124.7 ELOVL1 Ssc1 ENSG00000066322 ELOVL fatty acid elongase 1 1 43363397-43368074 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB033426, HPA056557 Approved Approved Endoplasmic reticulum Expressed in all skin: 157.0 FITM1 FIT1 ENSG00000139914 Fat storage-inducing transmembrane protein 1 14 24131275-24132849 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA019842 Uncertain Group enriched 14 heart muscle: 45.3;skeletal muscle: 113.0 spleen: 5.5 FLVCR2 C14orf58, FLJ20371, MFSD7C ENSG00000119686 Feline leukemia virus subgroup C cellular receptor family, member 2 14 75578617-75663214 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037984 Supported Tissue enhanced 0 testis: 38.5 small intestine: 27.4 FRRS1 SDFR2, SDR2 ENSG00000156869 Ferric-chelate reductase 1 1 99708703-99766631 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA017883 Approved Mixed placenta: 15.7 GCGR GGR ENSG00000215644 Glucagon receptor 17 81804132-81814013 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071228 Approved Golgi apparatus Group enriched 7 adrenal gland: 6.6;kidney: 8.5;liver: 20.9;parathyroid gland: 9.4 skin: 1.6 GDPD5 GDE2, PP1665 ENSG00000158555 Glycerophosphodiester phosphodiesterase domain containing 5 11 75434640-75525903 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065257, HPA066762, HPA069281 Uncertain Approved Golgi apparatus Tissue enhanced 0 spleen: 68.0 testis: 31.2 GGCX VKCFD1 ENSG00000115486 Gamma-glutamyl carboxylase 2 85544723-85561547 Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018284 Approved Expressed in all liver: 61.2 GHITM DERP2, HSPC282, My021, PTD010, TMBIM5 ENSG00000165678 Growth hormone inducible transmembrane protein 10 84139440-84153555 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016464, HPA061664 Approved Supported Mitochondria Expressed in all kidney: 349.8 GHSR ENSG00000121853 Growth hormone secretagogue receptor 3 172445133-172448456 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level CAB012451 Uncertain Not detected adrenal gland: 0.3 GPER1 CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR ENSG00000164850 G protein-coupled estrogen receptor 1 7 1082208-1093815 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA027052 Approved Mixed placenta: 9.1 GPR137 C11orf4, GPR137A, TM7SF1L1 ENSG00000173264 G protein-coupled receptor 137 11 64270062-64289500 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062871 Uncertain Approved Nucleus
Nucleoli
Actin filaments Expressed in all testis: 147.8 GPR137C DKFZp762F0713, TM7SF1L2 ENSG00000180998 G protein-coupled receptor 137C 14 52553148-52637713 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003640, HPA030763 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 18.0;epididymis: 10.5 testis: 8.2 GPR149 IEDA, PGR10 ENSG00000174948 G protein-coupled receptor 149 3 154337672-154429715 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018020 Uncertain Tissue enriched 6 seminal vesicle: 2.9 testis: 0.4 GPR153 PGR1 ENSG00000158292 G protein-coupled receptor 153 1 6247346-6260975 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007159 Approved Mixed cervix: 17.3 GPR157 FLJ12132 ENSG00000180758 G protein-coupled receptor 157 1 9100305-9129170 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA028697 Uncertain Uncertain Nucleoli
Plasma membrane
Cell Junctions Mixed parathyroid gland: 23.9 GPR26 ENSG00000154478 G protein-coupled receptor 26 10 123666355-123694607 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA062736 Supported Tissue enriched 15 cerebral cortex: 4.3 testis: 0.2 GPR31 12-HETER, HETER1 ENSG00000120436 G protein-coupled receptor 31 6 167156271-167158329 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014014, HPA027108 Uncertain Tissue enhanced 0 lymph node: 1.6 spleen: 0.9 GPR39 ENSG00000183840 G protein-coupled receptor 39 2 132416574-132646559 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA022111 Approved Tissue enhanced 0 parathyroid gland: 17.7 colon: 6.2 GPR78 ENSG00000155269 G protein-coupled receptor 78 4 8558725-8619761 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013209 Uncertain Not detected adipose tissue: 0.0 GRINA HNRGW, LFG1, NMDARA1, TMBIM3 ENSG00000178719 Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) 8 143990058-143993415 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA036980, HPA036981 Approved Approved Nucleoli fibrillar center
Cytosol Expressed in all seminal vesicle: 261.5 HACD2 PTPLB ENSG00000206527 3-hydroxyacyl-CoA dehydratase 2 3 123490820-123585185 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB019282 Approved Expressed in all adipose tissue: 68.9 HACD3 B-ind1, HSPC121, PTPLAD1 ENSG00000074696 3-hydroxyacyl-CoA dehydratase 3 15 65530418-65578352 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014837, HPA060347 Approved Validated Nuclear membrane
Endoplasmic reticulum
Mitochondria
Cytosol Expressed in all cerebral cortex: 139.3 HGSNAT FLJ32731, HGNAT, TMEM76 ENSG00000165102 Heparan-alpha-glucosaminide N-acetyltransferase 8 43140455-43202855 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029578 Approved Expressed in all parathyroid gland: 50.4 HM13 dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1 ENSG00000101294 Histocompatibility (minor) 13 20 31514428-31577923 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045089, HPA056062 Approved Supported Endoplasmic reticulum Expressed in all cervix: 153.3 ICMT HSTE14, PCCMT, PPMT ENSG00000116237 Isoprenylcysteine carboxyl methyltransferase 1 6221193-6235972 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA032024, HPA032025 Uncertain Expressed in all parathyroid gland: 45.0 INSIG1 CL-6, MGC1405 ENSG00000186480 Insulin induced gene 1 7 155297776-155310235 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA071524 Approved Vesicles Expressed in all liver: 281.1 INSIG2 ENSG00000125629 Insulin induced gene 2 2 118088452-118110997 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB033861 Uncertain Expressed in all parathyroid gland: 27.9 ITPR2 CFAP48, IP3R2 ENSG00000123104 Inositol 1,4,5-trisphosphate receptor, type 2 12 26336515-26833198 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059144, HPA062260 Uncertain Supported Nucleus
Endoplasmic reticulum Mixed parathyroid gland: 25.7 JKAMP C14orf100, CDA06, HSPC213, HSPC327, JAMP ENSG00000050130 JNK1/MAPK8-associated membrane protein 14 59484443-59505410 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA031172, HPA071650 Supported Approved Nucleoplasm
Vesicles Expressed in all parathyroid gland: 74.7 KCNA1 AEMK, HUK1, Kv1.1, MBK1, RBK1 ENSG00000111262 Potassium channel, voltage gated shaker related subfamily A, member 1 12 4909905-4931361 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022365 Uncertain Tissue enriched 6 cerebral cortex: 13.5 parathyroid gland: 2.0 KCNA10 Kv1.8 ENSG00000143105 Potassium channel, voltage gated shaker related subfamily A, member 10 1 110517251-110518838 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA015061, CAB022564 Uncertain Uncertain Nucleoplasm
Cytosol Tissue enhanced 0 testis: 1.0 spleen: 0.2 KCNA2 HK4, Kv1.2 ENSG00000177301 Potassium channel, voltage gated shaker related subfamily A, member 2 1 110593580-110631474 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001976 Supported Tissue enriched 5 cerebral cortex: 20.7 thyroid gland: 3.8 KCNA3 HLK3, HPCN3, Kv1.3, MK3 ENSG00000177272 Potassium channel, voltage gated shaker related subfamily A, member 3 1 110672465-110675033 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016625 Approved Mixed lymph node: 10.7 KCNA4 HK1, HPCN2, KCNA4L, Kv1.4 ENSG00000182255 Potassium channel, voltage gated shaker related subfamily A, member 4 11 30009741-30017023 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001977, HPA016422 Approved Tissue enhanced 0 adrenal gland: 7.9;cerebral cortex: 4.3 heart muscle: 1.2 KCNB1 Kv2.1 ENSG00000158445 Potassium channel, voltage gated Shab related subfamily B, member 1 20 49363877-49484297 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001979, HPA042434 Supported Tissue enhanced 0 adipose tissue: 11.0;cerebral cortex: 21.0 fallopian tube: 7.5 KCNB2 Kv2.2 ENSG00000182674 Potassium channel, voltage gated Shab related subfamily B, member 2 8 72537391-72938349 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA065970 Approved Nucleoli
Plasma membrane
Midbody Tissue enhanced 0 cerebral cortex: 3.2;spleen: 3.4 testis: 0.7 KCNC1 Kv3.1 ENSG00000129159 Potassium channel, voltage gated Shaw related subfamily C, member 1 11 17734812-17783055 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047634, HPA048249 Supported Approved Nucleus
Nuclear membrane
Vesicles
Cytosol Tissue enriched 8 cerebral cortex: 16.5 testis: 1.9 KCNC2 Kv3.2 ENSG00000166006 Potassium channel, voltage gated Shaw related subfamily C, member 2 12 75040077-75209868 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019664, CAB022571 Uncertain Supported Plasma membrane
Cytosol Tissue enriched 11 cerebral cortex: 46.5 prostate: 4.2 KCNC3 Kv3.3, SCA13 ENSG00000131398 Potassium channel, voltage gated Shaw related subfamily C, member 3 19 50311937-50333515 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018041 Uncertain Tissue enhanced 0 parathyroid gland: 39.3 cerebral cortex: 19.9 KCND1 Kv4.1 ENSG00000102057 Potassium channel, voltage gated Shal related subfamily D, member 1 X 48961378-48971569 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA000524, HPA001066 Approved Approved Nucleus Mixed gallbladder: 4.0 KCND2 KIAA1044, Kv4.2, RK5 ENSG00000184408 Potassium channel, voltage gated Shal related subfamily D, member 2 7 120273668-120750331 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029068 Approved Tissue enhanced 0 cerebral cortex: 20.8 gallbladder: 6.9 KCND3 KSHIVB, Kv4.3, SCA19, SCA22 ENSG00000171385 Potassium channel, voltage gated Shal related subfamily D, member 3 1 111770662-111989155 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029452 Approved Mixed cerebral cortex: 26.8 KCNH1 eag, eag1, h-eag, Kv10.1 ENSG00000143473 Potassium channel, voltage gated eag related subfamily H, member 1 1 210678315-211134115 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014551, HPA019445 Supported Approved Vesicles Tissue enriched 12 cerebral cortex: 11.5 testis: 0.9 KCNH5 eag2, H-EAG2, Kv10.2 ENSG00000140015 Potassium channel, voltage gated eag related subfamily H, member 5 14 62699454-63102037 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA030487 Uncertain Uncertain Microtubules
Mitotic spindle Tissue enhanced 0 adrenal gland: 1.4;cerebral cortex: 3.6 testis: 0.7 KCNH7 erg3, HERG3, Kv11.3 ENSG00000184611 Potassium channel, voltage gated eag related subfamily H, member 7 2 162371407-162838730 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018039 Uncertain Tissue enriched 6 cerebral cortex: 4.7 testis: 0.7 KCNK1 DPK, K2p1.1, TWIK-1 ENSG00000135750 Potassium channel, two pore domain subfamily K, member 1 1 233614004-233672512 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016049, CAB022588 Approved Approved Vesicles Mixed cerebral cortex: 46.6 KCNK10 K2p10.1, PPP1R97, TREK-2, TREK2 ENSG00000100433 Potassium channel, two pore domain subfamily K, member 10 14 88180103-88326907 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030462 Approved Tissue enhanced 0 cerebral cortex: 5.6;duodenum: 5.3 small intestine: 2.8 KCNK13 K2p13.1, THIK-1, THIK1 ENSG00000152315 Potassium channel, two pore domain subfamily K, member 13 14 90061765-90185857 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003514 Approved Approved Nuclear speckles
Cell Junctions Tissue enhanced 0 parathyroid gland: 14.3;testis: 14.4 kidney: 3.3 KCNK17 K2p17.1, TALK-2, TALK2, TASK-4, TASK4 ENSG00000124780 Potassium channel, two pore domain subfamily K, member 17 6 39299001-39314553 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043892 Uncertain Tissue enhanced 0 lung: 5.6 placenta: 5.2 KCNK18 K2p18.1, TRESK, TRESK-2, TRESK2, TRIK ENSG00000186795 Potassium channel, two pore domain subfamily K, member 18 10 117197489-117210299 Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA044739 Uncertain Not detected testis: 0.2 KCNK2 K2p2.1, TREK-1 ENSG00000082482 Potassium channel, two pore domain subfamily K, member 2 1 215005775-215237093 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056054 Uncertain Approved Mitochondria
Cytosol Tissue enhanced 0 adrenal gland: 75.5 thyroid gland: 17.3 KCNK5 K2p5.1, TASK-2 ENSG00000164626 Potassium channel, two pore domain subfamily K, member 5 6 39188973-39229450 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059148 Uncertain Approved Nucleus Tissue enhanced 0 small intestine: 40.1 gallbladder: 29.6 KCNMA1 KCa1.1, mSLO1, SLO ENSG00000156113 Potassium channel, calcium activated large conductance subfamily M alpha, member 1 10 76869601-77638595 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054648 Approved Tissue enhanced 0 smooth muscle: 147.6 endometrium: 122.5 KCNN4 hIKCa1, hKCa4, hSK4, IK, KCa3.1 ENSG00000104783 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 19 43766533-43781257 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053841, HPA059622 Approved Tissue enhanced 0 salivary gland: 74.3 stomach: 37.1 KCNQ1 JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1 ENSG00000053918 Potassium channel, voltage gated KQT-like subfamily Q, member 1 11 2444684-2849109 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018656, HPA048553 Supported Tissue enhanced 0 adrenal gland: 134.2;thyroid gland: 102.8 seminal vesicle: 60.3 KCNQ2 BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2 ENSG00000075043 Potassium channel, voltage gated KQT-like subfamily Q, member 2 20 63400210-63472677 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016642, HPA057112 Approved Approved Endoplasmic reticulum Tissue enriched 7 cerebral cortex: 56.3 adrenal gland: 8.2 KCNQ4 DFNA2, Kv7.4 ENSG00000117013 Potassium channel, voltage gated KQT-like subfamily Q, member 4 1 40784012-40840452 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018305 Uncertain Mixed smooth muscle: 2.5 KCNQ5 Kv7.5 ENSG00000185760 Potassium channel, voltage gated KQT-like subfamily Q, member 5 6 72621792-73198851 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA016655 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 22.4 thyroid gland: 7.8 KCNS2 Kv9.2 ENSG00000156486 Potassium voltage-gated channel, modifier subfamily S, member 2 8 98427022-98432848 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA051417 Uncertain Tissue enhanced 0 cerebral cortex: 7.2 placenta: 2.2 KCNS3 Kv9.3 ENSG00000170745 Potassium voltage-gated channel, modifier subfamily S, member 3 2 17877847-18361616 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA014864 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Tissue enhanced 0 lung: 35.5 skeletal muscle: 29.6 KCNT1 KCa4.1, KIAA1422, SLACK, Slo2.2 ENSG00000107147 Potassium channel, sodium activated subfamily T, member 1 9 135702185-135795508 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059880 Uncertain Group enriched 5 cerebral cortex: 11.7;ovary: 3.9;skeletal muscle: 3.9;spleen: 6.7 testis: 1.2 KCNT2 KCa4.2, SLICK, SLO2.1 ENSG00000162687 Potassium channel, sodium activated subfamily T, member 2 1 196225779-196609225 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051218 Uncertain Approved Vesicles Tissue enhanced 0 ovary: 6.0 cerebral cortex: 3.5 MBOAT7 BB1, hMBOA-7, LENG4, LPIAT ENSG00000125505 Membrane bound O-acyltransferase domain containing 7 19 54173412-54189882 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055967 Approved Approved Cytosol Expressed in all cerebral cortex: 24.3 MCOLN1 ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1 ENSG00000090674 Mucolipin 1 19 7522626-7534009 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031763, CAB032637 Uncertain Supported Plasma membrane
Cytosol Expressed in all spleen: 49.0 MCOLN2 FLJ36691, TRP-ML2, TRPML2 ENSG00000153898 Mucolipin 2 1 84925583-84997113 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level HPA019114, HPA048999 Uncertain Supported Intermediate filaments Mixed rectum: 17.6 MCOLN3 FLJ11006, TRP-ML3, TRPML3 ENSG00000055732 Mucolipin 3 1 85018082-85048499 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018106, HPA062137 Approved Approved Nucleoli
Cytosol Tissue enhanced 0 adrenal gland: 57.9;parathyroid gland: 42.1 epididymis: 17.3 MFSD7 FLJ22269, LP2561 ENSG00000169026 Major facilitator superfamily domain containing 7 4 681829-689441 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043593 Uncertain Mixed parathyroid gland: 14.3 MIP AQP0, LIM1, MP26 ENSG00000135517 Major intrinsic protein of lens fiber 12 56449502-56469166 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014940 Supported Tissue enhanced 0 testis: 1.2 cerebral cortex: 0.2 MYADM ENSG00000179820 Myeloid-associated differentiation marker 19 53866223-53876437 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056301 Approved Nuclear speckles Expressed in all smooth muscle: 257.6 NDC1 FLJ10407, NET3, TMEM48 ENSG00000058804 NDC1 transmembrane nucleoporin 1 53765460-53838860 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069751, HPA070882 Approved Supported Nuclear membrane
Plasma membrane
Actin filaments Mixed lymph node: 16.6 NIPAL3 DJ462O23.2, NPAL3 ENSG00000001461 NIPA-like domain containing 3 1 24415794-24472976 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039978 Approved Approved Nucleoplasm Expressed in all prostate: 94.7 NOX4 KOX, KOX-1 ENSG00000086991 NADPH oxidase 4 11 89324356-89498187 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015475 Uncertain Approved Nucleus Tissue enriched 12 kidney: 133.6 parathyroid gland: 10.7 NPC1 ENSG00000141458 Niemann-Pick disease, type C1 18 23506184-23586898 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026618, CAB070132 Approved Expressed in all parathyroid gland: 110.9 NPC1L1 ENSG00000015520 NPC1-like 1 7 44512535-44541315 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB070127, CAB070128 Supported Tissue enhanced 0 duodenum: 58.7;small intestine: 59.3 liver: 14.2 OCSTAMP C20orf123, dJ257E24.3 ENSG00000149635 Osteoclast stimulatory transmembrane protein 20 46540946-46550574 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA031116 Uncertain Not detected testis: 0.2 OPN4 melanopsin, MOP ENSG00000122375 Opsin 4 10 86654557-86666848 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA039147 Approved Tissue enhanced 0 cerebral cortex: 2.2;parathyroid gland: 1.4 skeletal muscle: 0.9 OPN5 dJ402H5.1, neuropsin, TMEM13 ENSG00000124818 Opsin 5 6 47781982-47832780 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA026084 Supported Tissue enriched 42 testis: 4.3 heart muscle: 0.1 OPRD1 ENSG00000116329 Opioid receptor, delta 1 1 28812142-28871267 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013744 Uncertain Tissue enhanced 0 cerebral cortex: 2.6 adrenal gland: 0.8 OPRK1 KOR, OPRK ENSG00000082556 Opioid receptor, kappa 1 8 53225716-53251697 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB022595 Uncertain Group enriched 7 cerebral cortex: 3.6;prostate: 3.2;testis: 1.8 skeletal muscle: 0.3 OPRM1 MOR1 ENSG00000112038 Opioid receptor, mu 1 6 154010496-154246867 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014509, HPA067435 Supported Supported Tissue enhanced 0 testis: 4.2 esophagus: 1.2 OR10J3 OR10J3P ENSG00000196266 Olfactory receptor, family 10, subfamily J, member 3 1 159313670-159314659 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA042963 Uncertain Not detected placenta: 0.6 PAQR4 FLJ30002 ENSG00000162073 Progestin and adipoQ receptor family member IV 16 2969245-2973489 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA068394 Approved Vesicles Tissue enhanced 0 cerebral cortex: 54.1;parathyroid gland: 64.2 skin: 19.2 PCNXL4 C14orf135 ENSG00000126773 Pecanex-like 4 (Drosophila) 14 60091911-60169133 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA002076, HPA003390 Uncertain Approved Cytosol Expressed in all parathyroid gland: 31.6 PDE3A CGI-PDE ENSG00000172572 Phosphodiesterase 3A, cGMP-inhibited 12 20369245-20684381 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014492 Uncertain Supported Cytosol Tissue enhanced 0 heart muscle: 38.3 placenta: 31.1 PDE3B HcGIP1 ENSG00000152270 Phosphodiesterase 3B, cGMP-inhibited 11 14643723-14872044 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056111 Supported Endoplasmic reticulum Tissue enhanced 0 adipose tissue: 65.3 lymph node: 17.4 PGAP2 CWH43-N, FRAG1, MRT21 ENSG00000148985 Post-GPI attachment to proteins 2 11 3797724-3826371 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA063099 Approved Approved Microtubules Expressed in all epididymis: 258.9 PGAP3 CAB2, MGC9753, PER1, PERLD1, PP1498 ENSG00000161395 Post-GPI attachment to proteins 3 17 39671122-39696797 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA016591 Approved Approved Plasma membrane
Cytosol Expressed in all thyroid gland: 35.5 PHTF1 PHTF ENSG00000116793 Putative homeodomain transcription factor 1 1 113696831-113759489 Plasma proteins, Predicted membrane proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA059486 Approved Nucleoli
Nuclear bodies Tissue enhanced 0 testis: 54.1 parathyroid gland: 18.8 PIEZO2 C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771 ENSG00000154864 Piezo-type mechanosensitive ion channel component 2 18 10666483-11148762 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015986, HPA031974, HPA031975, HPA040616 Approved Approved Vesicles Mixed lung: 12.8 PIGB ENSG00000069943 Phosphatidylinositol glycan anchor biosynthesis, class B 15 55318960-55355648 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039929 Uncertain Uncertain Plasma membrane
Cytosol Mixed parathyroid gland: 22.8 PIGF ENSG00000151665 Phosphatidylinositol glycan anchor biosynthesis, class F 2 46580937-46617119 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA051389 Uncertain Expressed in all testis: 47.8 PKD2L1 PCL, PKD2L, PKDL, TRPP3 ENSG00000107593 Polycystic kidney disease 2-like 1 10 100288154-100330486 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022621 Uncertain Tissue enhanced 0 spleen: 10.0 lung: 3.4 PKD2L2 TRPP5 ENSG00000078795 Polycystic kidney disease 2-like 2 5 137887968-137942747 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041903, HPA043634 Approved Approved Plasma membrane
Cytosol Tissue enriched 11 testis: 15.6 thyroid gland: 1.4 PLPP1 LPP1, PAP-2a, PPAP2A ENSG00000067113 Phospholipid phosphatase 1 5 55424854-55535050 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033331, HPA047815 Supported Supported Plasma membrane Mixed prostate: 344.0 PLPP2 LPP2, PAP-2c, PPAP2C ENSG00000141934 Phospholipid phosphatase 2 19 281040-291504 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055540 Uncertain Approved Mitochondria Tissue enhanced 0 fallopian tube: 126.8 cervix: 91.2 PLPP3 LPP3, PAP-2b, PPAP2B ENSG00000162407 Phospholipid phosphatase 3 1 56494747-56645301 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028892, HPA072751 Uncertain Supported Golgi apparatus Expressed in all thyroid gland: 543.7 PLPP4 DPPL2, PPAPDC1, PPAPDC1A ENSG00000203805 Phospholipid phosphatase 4 10 120456954-120589855 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045188 Approved Approved Nucleus
Nucleoli Tissue enhanced 0 cerebral cortex: 17.2;gallbladder: 10.4;testis: 12.7 kidney: 7.7 PLPP5 DPPL1, HTPAP, PPAPDC1B ENSG00000147535 Phospholipid phosphatase 5 8 38263130-38269243 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA055777 Approved Vesicles Expressed in all prostate: 123.7 PLPPR1 FLJ20300, LPPR1, MGC26189, PRG-3 ENSG00000148123 Phospholipid phosphatase related 1 9 101028709-101325135 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014760, HPA014968, HPA014979 Supported Approved Nucleoplasm Group enriched 6 cerebral cortex: 23.9;kidney: 15.7 epididymis: 3.2 PLPPR2 LPPR2, PRG-4 ENSG00000105520 Phospholipid phosphatase related 2 19 11355386-11365698 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA048973 Uncertain Approved Nucleoplasm Expressed in all cerebral cortex: 77.4 PLPPR3 FLJ11535, LPPR3, PRG-2, PRG2 ENSG00000129951 Phospholipid phosphatase related 3 19 812488-821977 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052293, HPA057034 Uncertain Approved Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced 0 bone marrow: 6.1;cerebral cortex: 9.6;fallopian tube: 8.8 testis: 2.1 PLPPR5 LPPR5, PAP2, PAP2D, PRG5 ENSG00000117598 Phospholipid phosphatase related 5 1 98890245-99005032 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018072 Uncertain Approved Nucleus
Plasma membrane
Centrosome Group enriched 11 cerebral cortex: 12.0;testis: 4.0 adrenal gland: 0.7 POMT1 LGMD2K ENSG00000130714 Protein-O-mannosyltransferase 1 9 131502902-131523806 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065252 Approved Golgi apparatus Expressed in all testis: 62.7 PQLC1 FLJ22378 ENSG00000122490 PQ loop repeat containing 1 18 79902420-79951664 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051666 Uncertain Approved Nucleoplasm Expressed in all adipose tissue: 40.5 PQLC2 FLJ20320 ENSG00000040487 PQ loop repeat containing 2 1 19312326-19329300 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA057810 Approved Validated Vesicles Expressed in all testis: 16.3 PRRT4 ENSG00000224940 Proline-rich transmembrane protein 4 7 128350325-128361685 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA046373, HPA052681 Uncertain Approved Nucleoplasm
Peroxisomes
Plasma membrane Group enriched 12 adipose tissue: 15.7;bone marrow: 41.2 cerebral cortex: 2.3 RNF121 FLJ11099 ENSG00000137522 Ring finger protein 121 11 71928701-71997597 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046041 Uncertain Approved Nucleus
Golgi apparatus
Vesicles Expressed in all parathyroid gland: 27.9 RNF175 FLJ34190 ENSG00000145428 Ring finger protein 175 4 153710125-153760235 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035837 Uncertain Tissue enhanced 0 cerebral cortex: 13.2 seminal vesicle: 4.8 RYR2 ARVC2, ARVD2, VTSIP ENSG00000198626 Ryanodine receptor 2 (cardiac) 1 237042205-237833988 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020028 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 9 heart muscle: 68.2 cerebral cortex: 8.0 RYR3 ENSG00000198838 Ryanodine receptor 3 15 33310945-33866121 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062004 Uncertain Vesicles Tissue enhanced 0 parathyroid gland: 44.5 skeletal muscle: 13.3 SAMD8 FLJ25082, SMSr ENSG00000156671 Sterile alpha motif domain containing 8 10 75099586-75182123 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044402 Supported Endoplasmic reticulum Expressed in all cerebral cortex: 43.2 SCN2A HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2 ENSG00000136531 Sodium channel, voltage gated, type II alpha subunit 2 165239402-165392310 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022567 Supported Tissue enriched 22 cerebral cortex: 58.5 kidney: 2.7 SEC61A1 ENSG00000058262 Sec61 translocon alpha 1 subunit 3 128051641-128071683 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022076 Supported Endoplasmic reticulum Expressed in all cervix: 217.0 SERINC4 FLJ40363 ENSG00000184716 Serine incorporator 4 15 43794162-43800221 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018526 Uncertain Tissue enriched 10 testis: 2.2 endometrium: 0.2 SGMS1 MGC17342, MOB, SMS1, TMEM23 ENSG00000198964 Sphingomyelin synthase 1 10 50305586-50625163 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045191 Approved Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 114.4 SGMS2 MGC26963, SMS2 ENSG00000164023 Sphingomyelin synthase 2 4 107824563-107915047 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015076 Supported Mixed gallbladder: 64.5 SLC10A7 C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043 ENSG00000120519 Solute carrier family 10, member 7 4 146253975-146521964 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039996, HPA057906 Uncertain Approved Nucleoli Mixed epididymis: 16.0 SLC12A1 NKCC2 ENSG00000074803 Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 15 48191664-48304078 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014967, HPA018107 Supported Tissue enriched 456 kidney: 773.2 testis: 1.6 SLC12A4 KCC1 ENSG00000124067 Solute carrier family 12 (potassium/chloride transporter), member 4 16 67943474-67969601 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041138 Approved Approved Endosomes Expressed in all parathyroid gland: 62.5 SLC12A5 KCC2, KIAA1176 ENSG00000124140 Solute carrier family 12 (potassium/chloride transporter), member 5 20 46021690-46060152 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA072058 Supported Tissue enriched 8 cerebral cortex: 94.5 adrenal gland: 12.0 SLC15A3 hPTR3, PHT2 ENSG00000110446 Solute carrier family 15 (oligopeptide transporter), member 3 11 60937083-60952530 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA047880, HPA057642 Approved Supported Vesicles Expressed in all lung: 102.3 SLC16A1 MCT, MCT1 ENSG00000155380 Solute carrier family 16 (monocarboxylate transporter), member 1 1 112911847-112957013 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003324, CAB017489, HPA071055 Supported Validated Plasma membrane
Cell Junctions Mixed testis: 32.0 SLC16A10 MCT10, TAT1 ENSG00000112394 Solute carrier family 16 (aromatic amino acid transporter), member 10 6 111087503-111231194 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016860 Approved Approved Vesicles
Cell Junctions Tissue enhanced 0 placenta: 38.2 skin: 22.5 SLC16A2 AHDS, DXS128, MCT7, MCT8, MRX22, XPCT ENSG00000147100 Solute carrier family 16, member 2 (thyroid hormone transporter) X 74421461-74533917 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA072719 Approved Plasma membrane Mixed liver: 41.9 SLC16A3 MCT3, MCT4 ENSG00000141526 Solute carrier family 16 (monocarboxylate transporter), member 3 17 82228397-82261129 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017490, HPA021451 Approved Supported Nuclear membrane
Plasma membrane Expressed in all skeletal muscle: 74.4 SLC19A1 FOLT ENSG00000173638 Solute carrier family 19 (folate transporter), member 1 21 45493572-45544411 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024802 Approved Approved Plasma membrane Mixed duodenum: 22.6 SLC19A2 THTR1, TRMA ENSG00000117479 Solute carrier family 19 (thiamine transporter), member 2 1 169463909-169486003 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006119, HPA016599 Uncertain Approved Cytosol Expressed in all gallbladder: 49.3 SLC1A5 AAAT, ASCT2, M7V1, RDRC ENSG00000105281 Solute carrier family 1 (neutral amino acid transporter), member 5 19 46774883-46788594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035239, HPA035240 Supported Validated Plasma membrane Expressed in all epididymis: 117.4 SLC22A15 FLIPT1 ENSG00000163393 Solute carrier family 22, member 15 1 115976498-116070054 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019785 Approved Approved Vesicles Tissue enhanced 0 bone marrow: 20.5 skin: 11.1 SLC22A23 C6orf85, FLJ22174 ENSG00000137266 Solute carrier family 22, member 23 6 3268962-3457022 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014697 Approved Approved Nucleoplasm
Vesicles
Cytosol Expressed in all stomach: 28.2 SLC22A7 NLT, OAT2 ENSG00000137204 Solute carrier family 22 (organic anion transporter), member 7 6 43295694-43305538 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030220 Approved Group enriched 63 kidney: 50.1;liver: 167.4 testis: 1.7 SLC23A2 KIAA0238, SLC23A1, SVCT2, YSPL2 ENSG00000089057 Solute carrier family 23 (ascorbic acid transporter), member 2 20 4852356-5010293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052825, HPA059314 Approved Supported Golgi apparatus
Vesicles Expressed in all adrenal gland: 98.6 SLC24A1 CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX ENSG00000074621 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 15 65611366-65660995 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039370 Supported Approved Microtubules Mixed fallopian tube: 8.7 SLC25A17 PMP34 ENSG00000100372 Solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 22 40769630-40819399 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052708, HPA060972 Approved Supported Peroxisomes Expressed in all ovary: 24.0 SLC29A2 DER12, ENT2, HNP36 ENSG00000174669 Solute carrier family 29 (equilibrative nucleoside transporter), member 2 11 66362521-66372214 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018168 Approved Uncertain Nucleoplasm Tissue enhanced 0 skeletal muscle: 36.4 parathyroid gland: 21.8 SLC2A8 GLUT8, GLUTX1 ENSG00000136856 Solute carrier family 2 (facilitated glucose transporter), member 8 9 127397138-127408424 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011935 Uncertain Approved Vesicles Expressed in all testis: 50.1 SLC30A1 ZNT1, ZRC1 ENSG00000170385 Solute carrier family 30 (zinc transporter), member 1 1 211571568-211578742 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015275, HPA049000 Uncertain Supported Vesicles
Plasma membrane Mixed liver: 47.3 SLC30A10 DKFZp547M236, ZnT-10, ZNT8, ZRC1 ENSG00000196660 Solute carrier family 30, member 10 1 219685427-219958647 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017989 Uncertain Tissue enhanced 0 duodenum: 2.2;liver: 2.3 testis: 1.1 SLC30A2 ZNT2 ENSG00000158014 Solute carrier family 30 (zinc transporter), member 2 1 26037252-26046133 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA017979 Approved Vesicles Tissue enhanced 0 kidney: 21.9;thyroid gland: 42.3 pancreas: 16.5 SLC30A3 ZNT3 ENSG00000115194 Solute carrier family 30 (zinc transporter), member 3 2 27253684-27275817 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060505, HPA067637 Approved Approved Nucleus
Nucleoli
Vesicles
Cytosol Group enriched 14 cerebral cortex: 36.7;epididymis: 65.2;testis: 43.6 heart muscle: 3.4 SLC30A4 ZNT4 ENSG00000104154 Solute carrier family 30 (zinc transporter), member 4 15 45479611-45522807 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018178 Uncertain Tissue enriched 5 prostate: 64.1 testis: 11.8 SLC30A6 FLJ31101, ZNT6 ENSG00000152683 Solute carrier family 30 (zinc transporter), member 6 2 32165841-32224379 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055032, HPA057328 Uncertain Validated Golgi apparatus Expressed in all thyroid gland: 19.7 SLC35B4 FLJ14697, YEA4 ENSG00000205060 Solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4 7 134289332-134317051 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA049779 Approved Mixed cerebral cortex: 17.9 SLC36A1 LYAAT-1, PAT1, TRAMD3 ENSG00000123643 Solute carrier family 36 (proton/amino acid symporter), member 1 5 151437046-151492381 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035937 Approved Tissue enhanced 0 parathyroid gland: 64.1 duodenum: 45.5 SLC36A4 FLJ38932, PAT4 ENSG00000180773 Solute carrier family 36 (proton/amino acid symporter), member 4 11 93144171-93197964 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017887 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Mixed thyroid gland: 14.7 SLC37A3 DKFZp761N0624 ENSG00000157800 Solute carrier family 37, member 3 7 140293693-140404433 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA014713, HPA061841 Supported Cytosol Expressed in all endometrium: 72.5 SLC38A6 NAT-1 ENSG00000139974 Solute carrier family 38, member 6 14 60981114-61083733 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018508 Approved Approved Plasma membrane
Cell Junctions
Microtubules Mixed parathyroid gland: 24.3 SLC39A10 DKFZp564L2123, FLJ90515, KIAA1265 ENSG00000196950 Solute carrier family 39 (zinc transporter), member 10 2 195575977-195737702 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036512, HPA036513, HPA066087 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 78.0;thyroid gland: 79.0 prostate: 27.6 SLC39A13 FLJ25785 ENSG00000165915 Solute carrier family 39 (zinc transporter), member 13 11 47407132-47416501 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA043971 Approved Uncertain Cytosol Expressed in all placenta: 58.0 SLC39A14 KIAA0062, NET34, ZIP14 ENSG00000104635 Solute carrier family 39 (zinc transporter), member 14 8 22367249-22434129 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016508 Approved Approved Endoplasmic reticulum
Golgi apparatus
Plasma membrane Mixed liver: 202.8 SLC39A5 ENSG00000139540 Solute carrier family 39 (zinc transporter), member 5 12 56230049-56237846 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018423 Approved Nucleoplasm
Vesicles
Cytosol Group enriched 12 colon: 74.5;duodenum: 247.0;kidney: 114.6;liver: 85.7;pancreas: 53.1;rectum: 49.7;small intestine: 245.4 gallbladder: 10.0 SLC39A6 LIV-1 ENSG00000141424 Solute carrier family 39 (zinc transporter), member 6 18 36108532-36129385 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042377 Approved Expressed in all prostate: 209.0 SLC39A7 D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7 ENSG00000112473 Solute carrier family 39 (zinc transporter), member 7 6 33200445-33204439 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053999 Approved Supported Endoplasmic reticulum Expressed in all parathyroid gland: 40.2 SLC39A8 BIGM103 ENSG00000138821 Solute carrier family 39 (zinc transporter), member 8 4 102251041-102431258 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA038832, HPA038833 Approved Tissue enhanced 0 lung: 257.1 cervix: 128.6 SLC39A9 FLJ11274 ENSG00000029364 Solute carrier family 39, member 9 14 69398015-69462388 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA007921, HPA075390 Approved Approved Endoplasmic reticulum Expressed in all parathyroid gland: 44.1 SLC43A1 PB39, POV1, R00504 ENSG00000149150 Solute carrier family 43 (amino acid system L transporter), member 1 11 57484534-57515786 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018813, HPA018826 Supported Approved Golgi apparatus
Vesicles
Plasma membrane Expressed in all liver: 50.0 SLC46A1 HCP1, MGC9564, PCFT ENSG00000076351 Solute carrier family 46 (folate transporter), member 1 17 28394756-28407197 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011614 Approved Supported Plasma membrane
Cytosol Expressed in all duodenum: 97.7 SLC47A1 FLJ10847, MATE1 ENSG00000142494 Solute carrier family 47 (multidrug and toxin extrusion), member 1 17 19495385-19579034 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021987 Supported Tissue enhanced 0 adrenal gland: 139.0;kidney: 105.0 liver: 55.2 SLC4A5 NBC4 ENSG00000188687 Solute carrier family 4 (sodium bicarbonate cotransporter), member 5 2 74216242-74343414 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036621 Approved Group enriched 9 testis: 25.5;thyroid gland: 40.5 skin: 3.7 SLC4A8 NBC3 ENSG00000050438 Solute carrier family 4, sodium bicarbonate cotransporter, member 8 12 51391317-51515763 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031536 Uncertain Actin filaments Tissue enhanced 0 cerebral cortex: 14.6;testis: 15.4 ovary: 4.2 SLC6A15 FLJ10316, hv7-3, NTT73, SBAT1, V7-3 ENSG00000072041 Solute carrier family 6 (neutral amino acid transporter), member 15 12 84859488-84913615 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008609 Uncertain Approved Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 23.1 placenta: 5.5 SLC6A20 XT3, Xtrp3 ENSG00000163817 Solute carrier family 6 (proline IMINO transporter), member 20 3 45755450-45796535 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029873 Approved Tissue enhanced 0 duodenum: 25.1;small intestine: 19.7 gallbladder: 10.9 SLC7A5 CD98, D16S469E, E16, LAT1, MPE16 ENSG00000103257 Solute carrier family 7 (amino acid transporter light chain, L system), member 5 16 87830023-87869488 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052673, HPA056077 Approved Supported Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 90.5;testis: 84.4 bone marrow: 66.3 SLC7A7 LPI, y+LAT-1 ENSG00000155465 Solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 14 22773222-22829820 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036227 Approved Tissue enhanced 0 kidney: 279.7 parathyroid gland: 159.0 SLC7A8 LAT2, LPI-PC1 ENSG00000092068 Solute carrier family 7 (amino acid transporter light chain, L system), member 8 14 23125295-23183674 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB046015, HPA051950, HPA060672 Supported Tissue enriched 8 parathyroid gland: 1066.4 kidney: 131.5 SLC9B1 NHA1, NHEDC1 ENSG00000164037 Solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 4 102885048-103019739 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA035435, HPA058971, HPA065520 Uncertain Approved Mitochondria Tissue enriched 25 testis: 73.9 epididymis: 2.9 SLC9B2 FLJ23984, NHA2, NHEDC2 ENSG00000164038 Solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 4 103019868-103085829 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047008 Uncertain Approved Nucleoplasm
Cell Junctions Tissue enhanced 0 cerebral cortex: 32.6 liver: 20.5 SPNS1 HSpin1, LAT, nrs, PP2030, SPIN1, SPINL ENSG00000169682 Spinster homolog 1 (Drosophila) 16 28974221-28984548 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041995, HPA042988 Supported Approved Nucleoli fibrillar center
Golgi apparatus
Vesicles
Cytosol Expressed in all parathyroid gland: 36.3 STEAP1 PRSS24, STEAP ENSG00000164647 Six transmembrane epithelial antigen of the prostate 1 7 90154375-90164829 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030985 Uncertain Tissue enhanced 0 prostate: 124.2 appendix: 41.5 STEAP2 IPCA-1, PCANAP1, STAMP1, STMP ENSG00000157214 STEAP family member 2, metalloreductase 7 90167590-90238137 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029115, HPA055603 Uncertain Supported Vesicles Tissue enriched 11 prostate: 205.1 parathyroid gland: 18.5 STEAP3 dudlin-2, STMP3, TSAP6 ENSG00000115107 STEAP family member 3, metalloreductase 2 119223831-119265652 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050510 Uncertain Approved Nucleoli
Cytosol Tissue enhanced 0 parathyroid gland: 190.8 liver: 53.0 STEAP4 FLJ23153, STAMP2, TIARP, TNFAIP9 ENSG00000127954 STEAP family member 4 7 88270892-88306891 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA075871 Supported Golgi apparatus Expressed in all adipose tissue: 129.9 SVOPL MGC46715 ENSG00000157703 SVOP-like 7 138594285-138701352 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018035 Uncertain Tissue enriched 5 parathyroid gland: 14.0 fallopian tube: 2.6 TAPT1 FLJ90013 ENSG00000169762 Transmembrane anterior posterior transformation 1 4 16160505-16227410 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042567, HPA048658 Approved Approved Vesicles Expressed in all cerebral cortex: 21.6 TMBIM6 BAXI1, BI-1, TEGT ENSG00000139644 Transmembrane BAX inhibitor motif containing 6 12 49707725-49764934 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017378 Approved Expressed in all kidney: 1179.3 TMEM101 FLJ23987, MGC4251 ENSG00000091947 Transmembrane protein 101 17 44011188-44023946 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039739 Approved Nucleoplasm
Plasma membrane Expressed in all seminal vesicle: 156.9 TMEM117 DKFZp434K2435 ENSG00000139173 Transmembrane protein 117 12 43835967-44389762 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046223 Uncertain Mixed seminal vesicle: 7.2 TMEM121 hole, MGC4659 ENSG00000184986 Transmembrane protein 121 14 105526603-105530202 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049857 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 4.8 spleen: 2.4 TMEM135 FLJ22104 ENSG00000166575 Transmembrane protein 135 11 87037844-87323758 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA056685, HPA069473 Uncertain Supported Vesicles Expressed in all adipose tissue: 31.8 TMEM136 MGC17839 ENSG00000181264 Transmembrane protein 136 11 120325129-120333682 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA074432 Approved Vesicles
Cytosol Mixed adrenal gland: 12.7 TMEM150C FLJ12993 ENSG00000249242 Transmembrane protein 150C 4 82483170-82562357 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA052921 Supported Tissue enhanced 0 epididymis: 179.7 ovary: 43.5 TMEM161A FLJ20422, FLJ39645 ENSG00000064545 Transmembrane protein 161A 19 19119169-19138513 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043365 Approved Approved Cytosol Expressed in all parathyroid gland: 20.9 TMEM163 DKFZP566N034, SV31 ENSG00000152128 Transmembrane protein 163 2 134455759-134719000 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA007224 Uncertain Mixed lung: 21.5 TMEM165 GDT1, TMPT27, TPARL ENSG00000134851 Transmembrane protein 165 4 55395957-55453397 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038299 Supported Supported Golgi apparatus
Vesicles Expressed in all placenta: 86.4 TMEM184B C22orf5, DKFZP586A1024, FM08, HS5O6A ENSG00000198792 Transmembrane protein 184B 22 38219291-38273034 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024076 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Expressed in all cerebral cortex: 57.5 TMEM185A CXorf13, FAM11A, FRAXF ENSG00000269556 Transmembrane protein 185A X 149596556-149631912 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048295, HPA071744 Uncertain Approved Endoplasmic reticulum Expressed in all ovary: 36.3 TMEM187 CXorf12, DXS9878E, ITBA1 ENSG00000177854 Transmembrane protein 187 X 153972327-153983195 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038134 Uncertain Approved Nucleoli
Cytosol Expressed in all fallopian tube: 11.2 TMEM19 FLJ10936 ENSG00000139291 Transmembrane protein 19 12 71686087-71705046 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016830 Approved Expressed in all kidney: 40.5 TMEM198 MGC99813, TMEM198A ENSG00000188760 Transmembrane protein 198 2 219543663-219550595 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042385, HPA056598 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 15.8 duodenum: 9.1 TMEM201 NET5, RP13-15M17.2 ENSG00000188807 Transmembrane protein 201 1 9588922-9614873 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB039039 Approved Supported Nucleus
Nuclear membrane Mixed testis: 9.9 TMEM229A ENSG00000234224 Transmembrane protein 229A 7 124030916-124033023 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056391 Uncertain Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 7.1;duodenum: 8.9;testis: 10.4 small intestine: 4.4 TMEM241 C18orf45, FLJ44259, MGC11386 ENSG00000134490 Transmembrane protein 241 18 23197144-23437961 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA029489, HPA059922 Uncertain Approved Golgi apparatus
Vesicles Mixed cerebral cortex: 4.3 TMEM245 C9orf5, CG-2 ENSG00000106771 Transmembrane protein 245 9 109015152-109119945 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023892 Approved Approved Plasma membrane
Cytosol Expressed in all thyroid gland: 123.5 TMEM259 ASBABP1, C19orf6, MBRL, MGC4022 ENSG00000182087 Transmembrane protein 259 19 1009648-1021179 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042669, HPA054801 Approved Approved Nuclear speckles
Endoplasmic reticulum Expressed in all spleen: 132.3 TMEM41A MGC15397 ENSG00000163900 Transmembrane protein 41A 3 185476496-185499057 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059101, HPA059790 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Expressed in all adrenal gland: 28.3 TMEM41B KIAA0033 ENSG00000166471 Transmembrane protein 41B 11 9280654-9314780 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014946 Uncertain Approved Peroxisomes Mixed thyroid gland: 22.3 TMEM44 DKFZp686O18124 ENSG00000145014 Transmembrane protein 44 3 194587673-194633689 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA043718 Uncertain Approved Cytosol Mixed epididymis: 15.8 TMEM64 DKFZp762C1112 ENSG00000180694 Transmembrane protein 64 8 90621995-90791632 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB034221 Uncertain Expressed in all epididymis: 173.0 TMEM86B MGC30208 ENSG00000180089 Transmembrane protein 86B 19 55226639-55229264 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057689 Uncertain Approved Midbody
Centrosome Mixed gallbladder: 6.6 TMEM8A M83, TMEM6, TMEM8 ENSG00000129925 Transmembrane protein 8A 16 370773-387113 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051281, HPA064673 Approved Supported Nucleoplasm
Cytokinetic bridge Expressed in all testis: 57.6 TMEM8C TMEM226 ENSG00000187616 Transmembrane protein 8C 9 133514586-133528612 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA051846, HPA055785 Uncertain Not detected epididymis: 0.5 TMEM94 KIAA0195 ENSG00000177728 Transmembrane protein 94 17 75441159-75500090 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008423, HPA050660 Approved Supported Nucleoplasm
Nuclear bodies Expressed in all cerebral cortex: 54.3 TRAM1 TRAM, TRAMP ENSG00000067167 Translocation associated membrane protein 1 8 70573442-70608387 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023929 Approved Expressed in all thyroid gland: 316.6 TRPA1 ANKTM1 ENSG00000104321 Transient receptor potential cation channel, subfamily A, member 1 8 72019917-72075617 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026630 Uncertain Tissue enhanced 0 urinary bladder: 30.5 gallbladder: 11.4 TRPC7 ENSG00000069018 Transient receptor potential cation channel, subfamily C, member 7 5 136213320-136365537 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level CAB022592, HPA031126 Uncertain Uncertain Actin filaments
Focal adhesion sites Not detected testis: 0.7 TRPM4 FLJ20041 ENSG00000130529 Transient receptor potential cation channel, subfamily M, member 4 19 49157741-49211836 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041169 Supported Supported Nucleoplasm
Plasma membrane Mixed colon: 27.5 TRPM5 LTRPC5, MTR1 ENSG00000070985 Transient receptor potential cation channel, subfamily M, member 5 11 2404515-2423045 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042115, HPA043315 Approved Group enriched 5 colon: 1.0;duodenum: 3.0;epididymis: 2.2;seminal vesicle: 2.5;small intestine: 2.9 thyroid gland: 0.4 TRPM7 CHAK1, LTRPC7, TRP-PLIK ENSG00000092439 Transient receptor potential cation channel, subfamily M, member 7 15 50552473-50686815 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035523, HPA052173 Uncertain Approved Nucleoplasm Tissue enriched 7 parathyroid gland: 212.8 thyroid gland: 29.0 TRPV2 VRL, VRL-1, VRL1 ENSG00000187688 Transient receptor potential cation channel, subfamily V, member 2 17 16415542-16437003 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044993 Uncertain Supported Plasma membrane Mixed lung: 44.1 TRPV3 VRL3 ENSG00000167723 Transient receptor potential cation channel, subfamily V, member 3 17 3510502-3557995 Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA069550 Approved Plasma membrane
Centrosome
Cytosol Tissue enhanced 0 skin: 5.2;small intestine: 4.6 duodenum: 1.7 TRPV4 CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC ENSG00000111199 Transient receptor potential cation channel, subfamily V, member 4 12 109783085-109833401 Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007150 Uncertain Mixed kidney: 11.8 TRPV5 CaT2, ECAC1 ENSG00000127412 Transient receptor potential cation channel, subfamily V, member 5 7 142908101-142933808 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA063175 Approved Not detected kidney: 0.5 TRPV6 CaT1, ECAC2 ENSG00000165125 Transient receptor potential cation channel, subfamily V, member 6 7 142871203-142885762 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA062864 Approved Tissue enhanced 0 prostate: 38.7;salivary gland: 29.3 placenta: 17.4 UNC50 GMH1, UNCL, URP ENSG00000115446 Unc-50 homolog (C. elegans) 2 98608579-98618515 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027009 Approved Expressed in all thyroid gland: 105.7 VN1R1 V1RL1, VNR19I1, ZVNH1, ZVNR1 ENSG00000178201 Vomeronasal 1 receptor 1 19 57454790-57457142 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062209 Uncertain Nucleus
Vesicles Mixed epididymis: 2.8 XKR6 C8orf21, C8orf5, C8orf7 ENSG00000171044 XK, Kell blood group complex subunit-related family, member 6 8 10896045-11201366 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA024828 Uncertain Mixed testis: 1.8 YIPF7 FinGER9, FLJ39576 ENSG00000177752 Yip1 domain family, member 7 4 44622065-44678556 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA030642 Uncertain Tissue enriched 42 skeletal muscle: 29.6 esophagus: 0.7 ZDHHC13 FLJ10852, FLJ10941, HIP14L ENSG00000177054 Zinc finger, DHHC-type containing 13 11 19117099-19176422 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016759, HPA018791 Uncertain Validated Vesicles Mixed esophagus: 40.5 ZDHHC17 HIP14, HYPH, KIAA0946 ENSG00000186908 Zinc finger, DHHC-type containing 17 12 76763588-76853696 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016807 Approved Supported Golgi apparatus
Vesicles
Cytosol Expressed in all cerebral cortex: 45.4